Annual Current Liabilities
$25.80 M
+$721.00 K+2.88%
December 31, 2023
Summary
- As of February 8, 2025, EFTR annual total current liabilities is $25.80 million, with the most recent change of +$721.00 thousand (+2.88%) on December 31, 2023.
- During the last 3 years, EFTR annual current liabilities has risen by +$17.02 million (+193.84%).
- EFTR annual current liabilities is now at all-time high.
Performance
EFTR Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$25.57 M
-$227.00 K-0.88%
March 31, 2024
Summary
- As of February 8, 2025, EFTR quarterly total current liabilities is $25.57 million, with the most recent change of -$227.00 thousand (-0.88%) on March 31, 2024.
- Over the past year, EFTR quarterly current liabilities has dropped by -$1.08 million (-4.06%).
- EFTR quarterly current liabilities is now -44.83% below its all-time high of $46.35 million, reached on September 30, 2021.
Performance
EFTR Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
EFTR Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.9% | -4.1% |
| 3 y3 years | +193.8% | -4.1% |
| 5 y5 years | +193.8% | -4.1% |
EFTR Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +548.5% | -4.1% | +872.2% |
| 5 y | 5-year | at high | +548.5% | -44.8% | +872.2% |
| alltime | all time | at high | +548.5% | -44.8% | +872.2% |
EFFECTOR Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $25.57 M(-0.9%) |
| Dec 2023 | $25.80 M(+2.9%) | $25.80 M(+9.4%) |
| Sep 2023 | - | $23.59 M(-0.7%) |
| Jun 2023 | - | $23.76 M(-10.9%) |
| Mar 2023 | - | $26.65 M(+6.3%) |
| Dec 2022 | $25.07 M | $25.07 M(+0.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $24.97 M(+5.9%) |
| Jun 2022 | - | $23.59 M(+796.8%) |
| Mar 2022 | - | $2.63 M(-33.9%) |
| Dec 2021 | $3.98 M(-54.7%) | $3.98 M(-91.4%) |
| Sep 2021 | - | $46.35 M(+427.9%) |
| Dec 2020 | $8.78 M | $8.78 M |
FAQ
- What is eFFECTOR Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics annual current liabilities year-on-year change?
- What is eFFECTOR Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics quarterly current liabilities year-on-year change?
What is eFFECTOR Therapeutics annual total current liabilities?
The current annual current liabilities of EFTR is $25.80 M
What is the all time high annual current liabilities for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high annual total current liabilities is $25.80 M
What is eFFECTOR Therapeutics annual current liabilities year-on-year change?
Over the past year, EFTR annual total current liabilities has changed by +$721.00 K (+2.88%)
What is eFFECTOR Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of EFTR is $25.57 M
What is the all time high quarterly current liabilities for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high quarterly total current liabilities is $46.35 M
What is eFFECTOR Therapeutics quarterly current liabilities year-on-year change?
Over the past year, EFTR quarterly total current liabilities has changed by -$1.08 M (-4.06%)